These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 372663)
1. [Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl)]. Baba H; Shinkai A; Azuma Y Kekkaku; 1979 Jan; 54(1):29-36. PubMed ID: 372663 [No Abstract] [Full Text] [Related]
2. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)]. Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258 [No Abstract] [Full Text] [Related]
3. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
4. [Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)]. Baba H; Shinkai A; Azuma Y Kekkaku; 1978 May; 53(5):287-94. PubMed ID: 671950 [No Abstract] [Full Text] [Related]
5. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028 [TBL] [Abstract][Full Text] [Related]
6. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis]. Chu N; Yan B; Zhu L Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873 [TBL] [Abstract][Full Text] [Related]
7. Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report. Swaminathan S; Raghavan A; Duraipandian M; Kripasankar AS; Ramachandran P Int J Tuberc Lung Dis; 2005 Jun; 9(6):693-6. PubMed ID: 15971400 [TBL] [Abstract][Full Text] [Related]
8. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis]. Sodikov ES; Abrarov BA Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322 [No Abstract] [Full Text] [Related]
9. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877 [TBL] [Abstract][Full Text] [Related]
11. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study]. Eule H; Beck H; Evers H; Fischer P; Kwiatkowski H; Merkel S; Reech R; Sieler R; Thomas E; Weinecke W Z Erkr Atmungsorgane; 1986; 167(1-2):29-41. PubMed ID: 3532585 [TBL] [Abstract][Full Text] [Related]
12. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)]. Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746 [No Abstract] [Full Text] [Related]
13. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
14. [Clinical trial of initial intensive short-course chemotherapy supplemented by pyrazinamide for pulmonary tuberculosis--report of the 26th A series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)]. Kekkaku; 1986 Jul; 61(7):363-9. PubMed ID: 3531659 [No Abstract] [Full Text] [Related]
15. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus]. Kameda K; Kawabata S; Masuda N Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255 [TBL] [Abstract][Full Text] [Related]
16. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE; Zierski M; Graczyk J; Bek E; Farer LS Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of intermittent chemotherapy with initial intensive regimen in original treatment for pulmonary tuberculosis. Report of the 18th series of controlled trial of chemotherapy (author's transl)]. Kekkaku; 1977 Jul; 52(7):345-51. PubMed ID: 909221 [No Abstract] [Full Text] [Related]
18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council]. Chaulet P Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970 [No Abstract] [Full Text] [Related]
20. [Efficacy of unfixed continuation phase short-course chemotherapy]. Xiao C; Fu Y; Li Z Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]